Format

Send to

Choose Destination
Aging (Albany NY). 2016 Feb;8(2):208-9.

The longevity transporter mIndy (Slc13a5) as a target for treating hepatic steatosis and insulin resistance.

Author information

1
Section of Metabolic Vascular Medicine, Medical Clinic III, Dresden University School of Medicine, Technische Universit├Ąt Dresden, Dresden, Germany.
2
Paul Langerhans Institute Dresden (PLID), German Center for Diabetes Research (DZD), Dresden, Germany.
3
Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA.

KEYWORDS:

INDY; Slc13a5; aging; fatty liver; longevity; type 2 diabetes

PMID:
26928109
PMCID:
PMC4789574
DOI:
10.18632/aging.100907
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center